TC(SH:603421)2024-04-29 12:07Financial Performance - The company's operating revenue for Q1 2024 was CNY 468,418,887.72, representing a year-on-year increase of 0.83%[5]. - The net profit attributable to shareholders was a loss of CNY 104,694,271.93, with a significant decline attributed to increased R&D expenses[5][10]. - The basic and diluted earnings per share were both CNY -0.16, reflecting the decline in net profit[5]. - Net profit for Q1 2024 was a loss of CNY 104,694,271.93, compared to a loss of CNY 58,177,715.03 in Q1 2023, representing an increase in loss of 80.00%[21]. - Operating profit for Q1 2024 was -¥58,173,379.44, a decline from -¥22,369,020.02 in Q1 2023[30]. - Net profit for Q1 2024 was -¥58,003,812.43, compared to -¥21,938,808.92 in the same period last year[31]. Cash Flow - The net cash flow from operating activities was a negative CNY 105,192,120.79, primarily due to increased payments for goods and employee compensation[5][10]. - Cash flow from operating activities showed a net outflow of CNY 105,192,120.79, worsening from a net outflow of CNY 19,254,120.86 in the previous year[24]. - Cash flow from operating activities for Q1 2024 was -¥87,853,354.45, worsening from -¥29,686,922.52 in Q1 2023[32]. - The total cash inflow from operating activities was ¥561,585,447.47 in Q1 2024, down from ¥638,708,456.75 in Q1 2023[31]. - The total cash outflow from operating activities was ¥649,438,801.92 in Q1 2024, compared to ¥668,395,379.27 in Q1 2023[32]. - The net cash flow from investment activities was -CNY 16,171,463.49, a decrease compared to the previous quarter's -CNY 8,876,886.37[25]. Assets and Liabilities - Total assets decreased by 6.06% from the end of the previous year, amounting to CNY 5,561,099,856.83[6]. - Total assets as of March 31, 2024, were ¥5,561,099,856.83, down 6.1% from ¥5,919,564,184.46 at the end of 2023[16]. - Total liabilities decreased to ¥2,246,641,999.43 from ¥2,500,412,055.13, a reduction of 10.1%[17]. - The company reported a total current liabilities of ¥1,680,613,583.04, down 10.9% from ¥1,885,715,391.24[17]. - The total liabilities decreased to CNY 1,680,451,288.98 from CNY 1,849,052,524.94, reflecting a reduction of about 9.14%[28]. - The company's total equity decreased to CNY 3,703,281,690.09 from CNY 3,761,285,502.52, a decline of approximately 1.54%[28]. Research and Development - The company plans to continue focusing on R&D and product development to improve future performance[10]. - Research and development expenses rose to CNY 127,020,116.58, an increase of 19.84% from CNY 106,007,956.94 in Q1 2023[20]. - Research and development expenses for Q1 2024 were ¥80,123,814.64, up from ¥77,965,350.93 in Q1 2023[30]. Other Income and Expenses - Non-recurring gains and losses included a government subsidy of CNY 486,159.31, which is closely related to the company's normal operations[7][10]. - Other income decreased significantly to CNY 12,241,064.88 from CNY 26,145,525.31 in Q1 2023[20]. - The company reported a significant increase in credit impairment losses, totaling CNY -4,120,771.33 compared to CNY -1,042,299.27 in the previous year[21]. Regulatory and Market Presence - The company received a notice from the China Securities Regulatory Commission regarding an investigation for suspected information disclosure violations[13]. - The company plans to focus on expanding its market presence and enhancing product development in the upcoming quarters[20].